Synthesis of highly immunogenic multiple antigenic peptides for epitopes of viral antigen to use in ELISA

International Journal of Peptide Research and Therapeutics

Volumn 15, Issue 4, 2009, Pages 313-321

  Saravanan, Paramasivam ^a,b   Shrivastava, Sameer ^a   Kumar, Satish ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Anti peptide antibody; Antibody detection; Diagnostics; Epitope mapping; Immunogenic peptides; Multiple antigenic peptides

Indexed keywords

EPITOPE; PEPTIDE ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; IMMUNIZATION; NONHUMAN; PATHOGENESIS; PEPTIDE SYNTHESIS; RABBIT; SOLID PHASE SYNTHESIS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 70350786281     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-009-9193-0     Document Type: Article

References (17)

1. G Amexis NS Young 2007 Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus Viral Immunol 20 657 663 10.1089/vim.2007.0029 1:CAS:528:DC%2BD2sXhsVKitb%2FP 18158738
2. JP Briand C Barin MH Van Regenmortel S Muller 1992 Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies J Immunol Methods 156 255 265 10.1016/0022-1759(92)90033-P 1:CAS:528:DyaK3sXht1amsrc%3D 1474260 (Pubitemid 23017225)
3. HJ Dechamma V Dighe CA Kumar RP Singh M Jagadish S Kumar 2006 Identification of T-helper and linear B epitope in the hypervariable region of nucleocapsid protein of PPRV and its use in the development of specific antibodies to detect viral antigen Vet Microbiol 118 201 211 10.1016/j.vetmic.2006.07.023 1:CAS:528:DC%2BD28Xht1CgsLfI 16962260 (Pubitemid 44781160)
4. MJ Francis GZ Hastings F Brown J McDermed YA Lu JP Tam 1991 Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot and mouth disease virus Immunology 73 249 254 1:CAS:528:DyaK3MXlvVSqt7c%3D 1652552
5. A Habluetzel A Pessi E Bianchi G Rotigliano F Esposito 1991 Multiple antigen peptides for specific detection of antibodies to a malaria antigen in human sera Immunol Lett 30 75 80 10.1016/0165-2478(91)90092-O 1:CAS:528:DyaK38XjvFaguw%3D%3D 1720420
6. MW Jackwood DA Hilt 1995 Production and immunogenicity of multiple antigenic peptide (MAP) constructs derived from the S1 glycoprotein of infectious bronchitis virus (IBV) Adv Exp Med Biol 380 213 219 1:CAS:528:DyaK28XisFylsb8%3D 8830482
7. RA Lerner 1982 Tapping the immunological repertoire to produce antibodies of predetermined specificity Nature 299 592 596 10.1038/299592a0 1:CAS:528:DyaL3sXhtVGmsrg%3D (Pubitemid 12033271)
8. GW McLean AM Owsianka JH Subak-Sharpe HS Marsden 1991 Generation of anti-peptide and anti-protein sera: effect of peptide presentation on immunogenicity J Immonol Methods 137 149 157 10.1016/0022-1759(91)90019-C 1:CAS:528:DyaK3MXksVOgur4%3D
9. RB Merrifield 1963 Solid phase peptide synthesis I. The synthesis of tetrapeptide J Am Chem Soc 85 2149 2154 10.1021/ja00897a025 1:CAS:528: DyaF3sXksVajsLg%3D
10. D Nardelli DR Luyashia DC Delprre AT Profy JP Tam 1992 A chemically defined synthetic vaccine model for HIV-I J Immunol 148 914 920 1:CAS:528:DyaK38Xht1Kntr8%3D 1370524
11. A Pessi D Valmori P Migliorni, et al. 1991 Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide Eur J Immunol 21 2273 2276 10.1002/eji.1830210941 1:CAS:528:DyaK38XkslOl 1889465
12. P Saravanan S Kumar JM Kataria 2004 Use of multiple antigenic peptides related to antigenic determinants of infectious bursal disease virus (IBDV) for detection of anti-IBDV-specific antibody in ELISA-quantitative comparison with native antigen for their use in serodiagnosis J Immunol Methods 293 61 70 10.1016/j.jim.2004.07.001 1:CAS:528:DC%2BD2cXpsFCitL4%3D 15541277 (Pubitemid 39468332)
13. P Simmonds KA Rose S Graham, et al. 1993 Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 J Clin Microbiol 31 1493 1503 1:CAS:528:DyaK3sXltFGjs7k%3D 7686182
14. WJ Syu L Kahan 1991 Characterization of antigenic structures by mapping on resin-bound epitope analogs Methods Enzymol 203 292 300
15. JP Tam 1988 Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system Proc Natl Acad Sci USA 85 5409 5413 10.1073/pnas.85.15.5409 1:CAS:528:DyaL1cXls1ynuro%3D 3399498 (Pubitemid 18207061)
16. JP Tam YA Lu 1989 Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B- cell epitopes Proc Natl Acad Sci USA 86 9084 9088 10.1073/pnas.86.23.9084 1:CAS:528:DyaK3cXhtVClsb0%3D 2480595 (Pubitemid 20010369)
17. L Zaccaro A Del Gatto C Pedone M Saviano 2009 Peptides for tumour therapy and diagnosis: current status and future directions Curr Med Chem 16 780 795 10.2174/092986709787549307 1:CAS:528:DC%2BD1MXjsFWhurc%3D 19275595